# Essex Property Trust, Inc.: financial statements, quarterly

ESS · NYSE · CIK 920522 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ess.md) · [Financials](/companies/ess/financials.md) · [Filings](/companies/ess/filings.md) · [Insiders](/companies/ess/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ess/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2.8](/filings/0000920522-24-000092.md) | [2.8 d](/filings/0000920522-26-000003.md) | [2.7](/filings/0000920522-25-000040.md) | [2.6](/filings/0000920522-25-000078.md) | [2.6](/filings/0000920522-25-000082.md) | [2.4 d](/filings/0000920522-26-000003.md) | [2.5](/filings/0000920522-26-000016.md) | [2.2](/filings/0000920522-26-000022.md) | [2.4](/filings/0000920522-25-000082.md) | [2.3 d](/filings/0000920522-26-000003.md) | [2.3](/filings/0000920522-26-000016.md) | [2.3](/filings/0000920522-26-000022.md) |
| Gross profit | $m | not reported | not reported | [298](/filings/0000920522-25-000040.md) | [313](/filings/0000920522-25-000078.md) | [313](/filings/0000920522-25-000082.md) | [318 d](/filings/0000920522-26-000003.md) | [323](/filings/0000920522-26-000016.md) | [332](/filings/0000920522-26-000022.md) | [328](/filings/0000920522-25-000082.md) | [336 d](/filings/0000920522-26-000003.md) | [341](/filings/0000920522-26-000016.md) | [346](/filings/0000920522-26-000022.md) |
| Operating income | $m | [132](/filings/0000920522-24-000092.md) | [130 d](/filings/0000920522-26-000003.md) | [132](/filings/0000920522-25-000040.md) | [137](/filings/0000920522-25-000078.md) | [129](/filings/0000920522-25-000082.md) | [304 d](/filings/0000920522-26-000003.md) | [257](/filings/0000920522-26-000016.md) | [280](/filings/0000920522-26-000022.md) | [210](/filings/0000920522-25-000082.md) | [152 d](/filings/0000920522-26-000003.md) | [155](/filings/0000920522-26-000016.md) | [109](/filings/0000920522-26-000022.md) |
| Interest expense | $m | [54.2](/filings/0000920522-23-000042.md) | [55.1 d](/filings/0000920522-24-000033.md) | [55.9](/filings/0000920522-24-000045.md) | [59.1](/filings/0000920522-24-000075.md) | [59.2](/filings/0000920522-25-000082.md) | [61.2 d](/filings/0000920522-26-000003.md) | [62.7](/filings/0000920522-26-000016.md) | [65.3](/filings/0000920522-26-000022.md) | [64.7](/filings/0000920522-25-000082.md) | [65.8 d](/filings/0000920522-26-000003.md) | [65.6](/filings/0000920522-26-000016.md) | [66.8](/filings/0000920522-26-000022.md) |
| Net income | $m | [93.0](/filings/0000920522-24-000092.md) | [70.3 d](/filings/0000920522-26-000003.md) | [285](/filings/0000920522-25-000040.md) | [99.0](/filings/0000920522-25-000078.md) | [125](/filings/0000920522-25-000082.md) | [302 d](/filings/0000920522-26-000003.md) | [213](/filings/0000920522-26-000016.md) | [232](/filings/0000920522-26-000022.md) | [173](/filings/0000920522-25-000082.md) | [85.7 d](/filings/0000920522-26-000003.md) | [112](/filings/0000920522-26-000016.md) | [66.9](/filings/0000920522-26-000022.md) |
| Diluted EPS | $ per share | [1.36](/filings/0000920522-24-000092.md) | not reported | [4.25](/filings/0000920522-25-000040.md) | [1.45](/filings/0000920522-25-000078.md) | [1.84](/filings/0000920522-25-000082.md) | not reported | [3.16](/filings/0000920522-26-000016.md) | [3.44](/filings/0000920522-26-000022.md) | [2.56](/filings/0000920522-25-000082.md) | not reported | [1.65](/filings/0000920522-26-000016.md) | [0.97](/filings/0000920522-26-000022.md) |
| Basic EPS | $ per share | [1.36](/filings/0000920522-24-000092.md) | not reported | [4.25](/filings/0000920522-25-000040.md) | [1.45](/filings/0000920522-25-000078.md) | [1.84](/filings/0000920522-25-000082.md) | not reported | [3.16](/filings/0000920522-26-000016.md) | [3.44](/filings/0000920522-26-000022.md) | [2.56](/filings/0000920522-25-000082.md) | not reported | [1.65](/filings/0000920522-26-000016.md) | [0.97](/filings/0000920522-26-000022.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.4](/filings/0000920522-24-000092.md) | [0.4](/filings/0000920522-26-000003.md) | [0.5](/filings/0000920522-25-000040.md) | [0.1](/filings/0000920522-25-000078.md) | [0.1](/filings/0000920522-25-000082.md) | [0.1](/filings/0000920522-26-000022.md) | [0.1](/filings/0000920522-26-000016.md) | [0.1](/filings/0000920522-26-000022.md) | [0.1](/filings/0000920522-25-000082.md) | [0.1](/filings/0000920522-26-000022.md) | [0.0](/filings/0000920522-26-000016.md) | [0.1](/filings/0000920522-26-000022.md) |
| Total assets | $bn | [12.5](/filings/0000920522-23-000042.md) | [12.4](/filings/0000920522-25-000024.md) | [12.9](/filings/0000920522-24-000045.md) | [12.5](/filings/0000920522-24-000075.md) | [12.6](/filings/0000920522-24-000092.md) | [12.9](/filings/0000920522-26-000003.md) | [13.2](/filings/0000920522-25-000040.md) | [13.2](/filings/0000920522-25-000078.md) | [13.2](/filings/0000920522-25-000082.md) | [13.2](/filings/0000920522-26-000022.md) | [13.1](/filings/0000920522-26-000016.md) | [12.9](/filings/0000920522-26-000022.md) |
| Total liabilities | $bn | [6.8](/filings/0000920522-23-000042.md) | [6.7](/filings/0000920522-25-000024.md) | [7.1](/filings/0000920522-24-000045.md) | [6.8](/filings/0000920522-24-000075.md) | [7.0](/filings/0000920522-24-000092.md) | [7.2](/filings/0000920522-26-000003.md) | [7.4](/filings/0000920522-25-000040.md) | [7.3](/filings/0000920522-25-000078.md) | [7.3](/filings/0000920522-25-000082.md) | [7.4](/filings/0000920522-26-000022.md) | [7.5](/filings/0000920522-26-000016.md) | [7.4](/filings/0000920522-26-000022.md) |
| Long-term debt | $bn | [6.2](/filings/0000920522-23-000042.md) | not reported | [6.6](/filings/0000920522-24-000045.md) | [6.2](/filings/0000920522-24-000075.md) | [6.4](/filings/0000920522-24-000092.md) | not reported | [6.8](/filings/0000920522-25-000040.md) | [6.4](/filings/0000920522-25-000078.md) | [6.4](/filings/0000920522-25-000082.md) | not reported | [6.8](/filings/0000920522-26-000016.md) | [6.4](/filings/0000920522-26-000022.md) |
| Shareholders' equity | $bn | [5.5](/filings/0000920522-23-000042.md) | [5.4](/filings/0000920522-25-000024.md) | [5.5](/filings/0000920522-24-000045.md) | [5.5](/filings/0000920522-24-000075.md) | [5.4](/filings/0000920522-24-000092.md) | [5.5](/filings/0000920522-26-000003.md) | [5.6](/filings/0000920522-25-000040.md) | [5.6](/filings/0000920522-25-000078.md) | [5.6](/filings/0000920522-25-000082.md) | [5.5](/filings/0000920522-26-000022.md) | [5.4](/filings/0000920522-26-000016.md) | [5.3](/filings/0000920522-26-000022.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [288 d](/filings/0000920522-24-000092.md) | [204 d](/filings/0000920522-26-000003.md) | [315](/filings/0000920522-25-000040.md) | [219 d](/filings/0000920522-25-000078.md) | [316 d](/filings/0000920522-25-000082.md) | [218 d](/filings/0000920522-26-000003.md) | [282](/filings/0000920522-26-000016.md) | [216 d](/filings/0000920522-26-000022.md) | [343 d](/filings/0000920522-25-000082.md) | [234 d](/filings/0000920522-26-000003.md) | [287](/filings/0000920522-26-000016.md) | [254 d](/filings/0000920522-26-000022.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0000920522-24-000092.md) | [0.0 d](/filings/0000920522-26-000003.md) | [0.0](/filings/0000920522-24-000045.md) | [0.0 d](/filings/0000920522-24-000075.md) | [0.0 d](/filings/0000920522-24-000092.md) | [0.0 d](/filings/0000920522-26-000003.md) | [0.0](/filings/0000920522-26-000016.md) | [0.0 d](/filings/0000920522-26-000022.md) | not reported | not reported | [50.2](/filings/0000920522-26-000016.md) | [11.7](/filings/0000920522-26-000022.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [65.1](/filings/0000920522-23-000042.md) | [64.5](/filings/0000920522-24-000045.md) | [64.2](/filings/0000920522-24-000075.md) | [64.2](/filings/0000920522-24-000092.md) | [64.2](/filings/0000920522-25-000040.md) | [64.2](/filings/0000920522-25-000078.md) | [64.3](/filings/0000920522-25-000082.md) | [64.3](/filings/0000920522-26-000016.md) | [64.4](/filings/0000920522-26-000022.md) | [64.4](/filings/0000920522-25-000082.md) | [64.5](/filings/0000920522-26-000016.md) | [64.3](/filings/0000920522-26-000022.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 64,268,439 at 2026-07-23, from the cover of the [10-Q filed 2026-07-30](/filings/0000920522-26-000022.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.